{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:24:59Z","timestamp":1791314699717,"version":"4.3.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Fund from Saitama Cardiovascular and Respiratory Center","award":["10DR"],"award-info":[{"award-number":["10DR"]}]},{"name":"Research Fund from Saitama Cardiovascular and Respiratory Center","award":["11DR"],"award-info":[{"award-number":["11DR"]}]},{"name":"Research Fund from Saitama Cardiovascular and Respiratory Center","award":["12DR"],"award-info":[{"award-number":["12DR"]}]},{"name":"Research Fund from Saitama Cardiovascular and Respiratory Center","award":["13DR"],"award-info":[{"award-number":["13DR"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.atherosclerosis.2015.06.028","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T02:03:58Z","timestamp":1436753038000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-5165","authenticated-orcid":false,"given":"Tetsuya","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ayaori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Uto-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25 Suppl.\u00a02","key":"10.1016\/j.atherosclerosis.2015.06.028_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5551\/jat.11452","article-title":"Background to discuss guidelines for control of plasma HDL-choleterol in Japan","volume":"19","author":"Yokoyama","year":"2012","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","article-title":"High-density lipoprotein: the clinical implications of recent studies","volume":"321","author":"Gordon","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib4","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/01.CIR.89.6.2533","article-title":"High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men","volume":"89","author":"Kitamura","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib7","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1373\/clinchem.2007.101923","article-title":"Laboratory assessment of HDL heterogeneity and function","volume":"54","author":"Movva","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4 Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2015.06.028_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","article-title":"A\u00a0reporting system on patients evaluated for coronary artery disease. report of the Ad Hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American heart association","volume":"51","author":"Austen","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2006.08.022","article-title":"Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese","volume":"194","author":"Cui","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Triglyceride coronary disease genetics consortium and emerging risk factors collaboration","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2169\/internalmedicine.53.1438","article-title":"Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis","volume":"53","author":"Endo","year":"2014","journal-title":"Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.atherosclerosis.2009.09.012","article-title":"Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the suita study","volume":"209","author":"Okamura","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research","volume":"115","author":"Ralph","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/rej.2009.0840","article-title":"Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity","volume":"12","author":"Berrougui","year":"2009","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dmrr.895","article-title":"Cellular cholesterol efflux to serum is impaired in diabetic nephropathy","volume":"24","author":"Zhou","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.06.028_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.5551\/jat.17210","article-title":"Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients","volume":"20","author":"Miyamoto-Sasaki","year":"2013","journal-title":"J.\u00a0Atheroscler. Thromb."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:24:59Z","timestamp":1537475099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015013829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0021915015013829"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}